The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
Angus Dalgleish, MD - The Role of LDN in the Management of Cancer (2017 Conference) (LDN, low dose naltrexone)
Prof. Angus Dalgleish: Well, I'm going to talk about LDN and cancer, and I'm coming from a very different, way of doing things. I was trained in some of my research at the Institute of Cancer Research, where you basically design drugs, put them in mice.
Nasha Winters, ND - Using LDN to Quell the Over-Reactive Autoimmune Conditions Triggered by Many of Today's Cancer Drugs (2019 Conference) (LDN, low dose naltrexone)
Cory Tichauer, ND - Immune Dysfunction in Post-Treatment Lyme Disease: Using Naltrexone to Balance Chronic Inflammation II (2019 Conference) (LDN, low dose naltrexone)
Terry Wingo - LDN Specialist, LDN Radio Show 20 April 2021 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Terry Wingo graduated from Auburn University in 1975 with a bachelor of science in Pharmacy. He has fellowships with the American College of Apothecaries and the American College of Veterinary Pharmacists.
Tara Thompson, PharmD - Compounding 101: The Basics of Compounding with Naltrexone (2019 Conference) (LDN, low dose naltrexone)
Tara Thompson, PharmD discusses the purpose of a compounding pharmacy, how to choose one, the benefits and limitations of compounding, and dosage forms. She give an overview of naltrexone, dosing of LDN in various conditions, and how to write a prescription for compounded naltrexone.
LDN 2019 Conference - Sunday Q&A (2019 Conference) (LDN, low dose naltrexone)
Presentations on the below and questions were asked in relation to:
LDN 2019 Conference - Saturday Afternoon Q&A (2019 Conference) (LDN, low dose naltrexone)
Presentations on the below and questions were asked in relation to:
LDN 2019 Conference - Saturday Morning Q&A (2019 Conference) (LDN, low dose naltrexone)
Presentations on the below and questions were asked in relation to:
LDN 2019 Conference - Friday Afternoon Q&A (2019 Conference) (LDN, low dose naltrexone)
Presentations on the below and questions were asked in relation to: